The current global financial crisis is like to hit Bio-tech and pharmaceutical companies due to a lack of funding for research and the discovery and production of many new drugs, according to Professor David Wield, Director of the Economic and Social Research Council's (ESRC) Edinburgh-based Innogen Centre, and chair of the recent international ESRC conference Genomics and Society: Reinventing…
Coronary heart disease (CHD) symptoms, presented in the context of a stressful life event, were identified as psychogenic when presented by women and organic when presented by men, which could help explain why there is often a delay in the assessment of women with CHD, according to research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) conference.
Investigating the appropriate use of procedures to open narrowed coronary arteries, e.g. angioplasty and stenting, researchers at UCSF (University of California, USA) found that less than 50% of Medicare patients had documented non-invasive stress testing prior to elective percutaneous coronary intervention, or PCI (clinical name for these procedures).
Life Science Austria (LISA) was presenting Austria's life sciences strengths at a joint exhibition stand at this year's MEDICA.
NeuroNexus Technologies and Philips Research announced that they have signed a joint research agreement to develop next-generation deep brain stimulation devices with the ambition to improve the treatment of neurological diseases and psychiatric disorders.
Cardiovascular risk in obese patients can be reduced up to 79% in those who undergo Roux-en-Y gastric bypass after other treatments have failed, compared with those who do not have this procedure, according to a study published in the American Journal of Cardiology (1/10/08).
There is now new hope for women around the world, with the launch of an early detection test for ovarian cancer, according to HealthLinx Limited. The test, developed in Melbourne by HealthLinx scientists in collaboration with ARL Pathology, is called the OvPlex™ Panel and works by identifying whether five biomarkers (proteins) are present in a blood sample.
Since the completion of the 13-year human genome project in 2003, molecular scientists have been delving deeper into the world of cells.
Turning a brilliant idea into a market-ready product can be a long and arduous task. The 10th Fresenius Inventors' Fair, taking place at Medica, could make that route easier for inventors.
Als Kongresspräsident lud Professor Stefan N. Willich von der Berliner Charité zur Diskussion über die Möglichkeit, dem Wunsch der Patienten nach integrierter medizinischer Versorgung nachzukommen. Denn bei chronischen oder Herz-Kreislauf-Erkrankungen zum Beispiel möchten die Menschen sowohl schulmedizinische Aufklärung und Behandlung durch ihren Arzt als auch…
Die erste am Universitätsklinikum Carl Gustav Carus vorgenommene Transplantation von Inselzellen aus einer Bauchspeicheldrüse verlief erfolgreich: Zwei Wochen nach dem Eingriff bildet die seit 51 Jahren an Diabetes Typ 1 erkrankte Patientin wieder körpereigenes Insulin. Die Transplantation ist Ergebnis einer über zwei Jahre dauernden, aufwendigen Aufbauarbeit an Uniklinikum und Medizinischer…
Middle ear inflammation often involves treatment with steroids and pseudo-epinephrine to reduce oedema, and antibiotics to combat primary bacterial infection or a secondary complication.
Siemens Healthcare has opened a new research centre in Cologne, where around 40 employees are developing new diagnostic tests to describe the molecular characteristics of breast cancer cells, to help physicians to select individual therapy.
The use of mammography to maintain breast health comes with a caveat: exposure of the breast to radiation, which can increase the susceptibility risk of breast cancer. Thus, using the lowest possible radiation dose for mammograms is of utmost importance.
London and Cambridge-based biopharmaceutical research firm Domainex Ltd has received a European patent for its Combinatorial Domain Hunting (CDH) Technology, which enables the cloning and expression of recombinant proteins, or parts of proteins (domains), from challenging molecular targets.
It is safe to take anticoagulants before core needle breast biopsies, according to a study performed at the Elizabeth Wende Breast Clinic in Rochester, NY.
Early suspicions of cancer, either from clinical evidence or medical imaging, are often followed up on biopsy. However, the removal of tissue for histological analysis can be uncomfortable for patients.
Currently, early detection of Prostate Cancer depends on an abnormal digital rectal examination and an elevated prostate-specific-antigen (PSA) level requiring a prostate biopsy, often associated with anxiety, discomfort, complications, and heavy expenses. The prostate-cancer-gene-3 (PCA3) test is a new PCa gene-based marker carried out with a urine sample.
The US Agency for Healthcare Research and Quality (AHRQ) will fund a new project to develop four computer-based decision-tools that will help clinicians and patients answering questions like: When to use genetic tests? How to deal with the results? Or which treatment could be the best?
Double reading is better than single reading - at least for the detection of small breast cancer. But a software could boost one readers functionality. UK-researchers found out that performance of a single reader using a computer-aided detection system may match the performance achieved by two readers.
German scientist Harald zur Hausen showed that oncogenic human papilloma virus (HPV) cause cervical cancer, the second most common cancer among women. Françoise Barré-Sinoussi and Luc Montagnier from France discovered HIV.
At the opening of the Johnson & Johnson Diabetes Institute in Paris experts took the opportunity to warn against the growing incidence of diabetes. They reinforced the believe that improved education measures as a key enabler for patients to better manage the condition. They predicted that in 2025 the number of people with diabetes wil have increased by 20 percent in Europe.
Now it seems to be proven: The reason why people in Mediterranean countries live longer and healthier can be connected with their nutrition. Researchers in Italy found that sticking rigidly to a full Mediterranean diet can help reduce deaths from major chronic diseases like heart disease, cancer, Parkinson's and Alzheimer's disease.
Yes, it is, according to a prospective cohort study published in CMAJ. The study was conducted by researchers from the Hong Kong Institute of Diabetes and Obesity, the Li Ka Shing Institute of Health Science and The Chinese University of Hong Kong. Their result: A V-shaped risk relation between LDL cholesterol and cancer in patients not receiving statin therapy.
Moving personalized medicine from promise to practice. Siemens Healthcare announces the early study findings of a new imaging biomarker for hypoxic tumors. This clinically problematic cells tend to be less responsive to standard treatment regimens. A probe that measures hypoxia could prove quite a useful tool for oncologists.
